ENFERMEDAD TROFOBLASTICA PDF

ENFERMEDAD TROFOBLASTICA GESTACIONAL Epidemiología. Embarazo en los extremos de la edad reproductiva. Multiparidad. ENFERMEDAD. TROFOBLÁSTICA GESTACIONAL MIP K. DENISSE CASTRO SÁNCHEZ. 4 / MALIGNAS GESTACIONAL CORIOCARCINOMA TUMOR. Bajo la denominación de Enfermedad Trofoblástica se agrupan las neoplasias desarrolladas a expensas de la placenta o de las células germinativas de las.

Author: Dotilar Gardarr
Country: Burma
Language: English (Spanish)
Genre: Travel
Published (Last): 4 August 2018
Pages: 363
PDF File Size: 20.31 Mb
ePub File Size: 20.7 Mb
ISBN: 349-8-51633-151-2
Downloads: 22417
Price: Free* [*Free Regsitration Required]
Uploader: Bramuro

Aspectos generales de los marcadores tumorales. Recognizes clinico pathological mainly 4 ways: Puede encontrarse en otras enfermedades malignas y benignas o incluso en pacientes sin enfermedad aparente. MT de muy elevada especificidad y sensibilidad. Trofoblashica de especificidad y sensibilidad variable. A tumor marker with a high sensitivity would be the one that is elevated in the majority of patients who present certain neoplasm, whereas specificity would be determined by those patients with normal levels of the tumor marker who do not present any type of neoplasm.

The choriocarcinoma is an unusual entity being chemosensitive clinical presentation with a renal subcapsular hematomas. Complete remission was obtained and frank imagenological reduction hematomas.

Javascript must be enabled for narrowing. Get permanent URL for this record. El uso de los MT tiene algunas limitaciones: Clinical application of tumour markers: A 28 years with complete hydatidiform trofohlastica A P in Marcadores tumorales en el tumor de primario desconocido.

We can say that, in general, due to the lack of high diagnostic sensitivity and specificity, tumor markers are not helpful for an early detection of neoplasms, but they do help to confirm a diagnosis already established by more trofbolastica methods.

  BOSONOGA KRALJICA PDF

37 – Enfermedad trofoblástica by Amilcar Luis Tinoco Salazar on Prezi Next

Thus, markers with high levels of sensitivity and specificity would allow for the detection trofoblasttica patients with cancer, and for their differentiation from healthy individuals or from patients with benign pathologies.

National Cancer Institute Consultado Ene Gestational trophoblastic disease and bilateral renal subcapsular hematoma, an unusual form of clinical presentation. Results 1 – 1 of 1.

Unidad de Medicina Paliativa. R M ab d- pelvic supports multiple hepatic hematomas secundarismo renal subcapsular.

There was a problem providing the content you requested

Por ello, el principal dato a tener en cuenta va a ser el cambio cuantitativo de los MT. The Trousseau Syndrome Revisited: En la literatura se han publicado algunos estudios que evidencian que los MT se solicitan frecuentemente de forma inadecuada. Cancer and venous thromboembolism.

El hallazgo de concentraciones elevadas de cualquier marcador, de forma aislada, tiene un valor limitado. Sociedad Valenciana de Medicina Familiar y Comunitaria. East Afr Med J. The presentation with renal and bilateral subcapsular hematoma is a rarity with few reports in the literature.

Si las cifras del marcador sufren un incremento continuo, se puede afirmar con bastante seguridad que el origen es tumoral. Our aim is to review the tumor markers most commonly used in our clinical practice, as well as some agreed recommendations on the indication of their determination in various tumors.

Medifam revista en la Internet. Es obvio que este MT ideal no existe por el momento. The clinical value of tumour markers in the management of ovarian cancer.

Standard Search Advanced Search. Eur J Int Med. These molecules, whose serum concentration also depends on the biological variability of the patient, are detectable in different biological fluids. Close Go to Workspace.

  ASPETTI DEL ROMANZO FORSTER PDF

The most common sites of ebfermedad are lung, liver and CN S. An audit of tumour marker requests in Northern Ireland. La utilidad de los marcadores tumorales viene determinada por la sensibilidad y especificidad de cada uno de ellos. Eur J Intern Med. Complejo Hospitalario y Universitario de Albacete. Sin embargo, a pesar de esta lejana referencia, la historia de los MT arranca fundamentalmente en la segunda mitad del siglo XX; hay que tener en cuenta que diversas sustancias que posteriormente se utilizaron como MT han sido descubiertas hace relativamente poco tiempo: The Association of Biochemists in Ireland.

Browsing Especialidad en Medicina Materno Fetal by Subject

Most markers also have a prognostic value at the time of diagnosis, since their concentration is related to tumor size. It aspects discussed diagnostic, prognostic and therapeutic. Review of commonly used serum tumor markers and their relevance for image interpretation. Enfermedad trofoblastica gestacional y hematoma renal bilateral subcapsular una forma inhabitual de presentacion clinica.

Related Record Related Record. Reference Number Reference Number. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.